ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000255100.1	Avagacestat	Bladder urothelial carcinoma	0.004406881	Resistant
ENSG00000255100.1	Avagacestat	Thyroid carcinoma	0.037637222	Sensitive